Document Detail


Neutral endopeptidase inhibition: could it have a role in the treatment of female sexual arousal disorder?
MedLine Citation:
PMID:  20412067     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Female sexual arousal disorder (FSAD) is the inability to attain or maintain an adequate lubrication-swelling response of sexual excitement. The potentiation of vascular responses leading to increased blood flow in clitoris and vagina has represented the main focus in the pharmacological treatment of FSAD, including the evaluation of the type 5 phosphodiesterase (PDE5) inhibitors. However, due to a lack of clear efficacy, there is no approved pharmacotherapy for FSAD to date. In the present issue of the British Journal of Pharmacology, Wayman et al. show that the administration by intravenous or intravaginal routes of a novel neutral endopeptidase inhibitor, UK-414,445, results in enhanced genital blood flow responses to pelvic nerve stimulation in female rabbits, without significantly affecting blood pressure. Neutral endopeptidase inhibition, by preserving vasoactive peptides such as vasoactive intestinal polypeptide, raises the possibility of a new pharmacological approach to the treatment of FSAD.
Authors:
Javier Angulo
Related Documents :
2100317 - Responses of bone and joint blood vessels in cats and rabbits to electrical stimulation...
1740777 - Safety studies with the university of melbourne multichannel electrotactile speech proc...
19922357 - Assessment of the outcomes of cerebral blood flow measurements after electrical stimula...
2035677 - Sympathetic nerve modulation of regional cerebral blood flow during asphyxia in newborn...
4704907 - Spectrum analysis in ultrasonic doppler blood flow monitoring: experience in its applic...
16262757 - Motivation, recruitment and retention of voluntary non-remunerated blood donors: a surv...
Publication Detail:
Type:  Comment; Journal Article    
Journal Detail:
Title:  British journal of pharmacology     Volume:  160     ISSN:  1476-5381     ISO Abbreviation:  Br. J. Pharmacol.     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-04-23     Completed Date:  2010-07-26     Revised Date:  2011-07-28    
Medline Journal Info:
Nlm Unique ID:  7502536     Medline TA:  Br J Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  48-50     Citation Subset:  IM    
Affiliation:
Departamento de Investigación, Hospital Universitario Ramón y Cajal, Madrid, Spain. javier.angulo@hrc.es
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Electric Stimulation
Female
Genitalia, Female / blood supply,  drug effects*,  innervation
Neprilysin / antagonists & inhibitors,  physiology*
Pelvis / innervation
Pentanoic Acids / pharmacology*,  therapeutic use
Rabbits
Regional Blood Flow / drug effects
Sexual Behavior, Animal / drug effects
Sexual Dysfunctions, Psychological / drug therapy*,  physiopathology
Thiadiazoles / pharmacology*,  therapeutic use
Vasoactive Intestinal Peptide / physiology
Chemical
Reg. No./Substance:
0/Pentanoic Acids; 0/Thiadiazoles; 0/UK-414,495; 37221-79-7/Vasoactive Intestinal Peptide; EC 3.4.24.11/Neprilysin
Comments/Corrections
Comment On:
Br J Pharmacol. 2010 May;160(1):51-9   [PMID:  20412068 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel dise...
Next Document:  UK-414,495, a selective inhibitor of neutral endopeptidase, potentiates pelvic nerve-stimulated incr...